Regenerative Medicine
Researchers Race to Build an HLA-Matched iPS Cell Bank for Most Americans
A landmark effort to bank immune-compatible stem cells matched to the majority of the US population — now terminated.
Clinical Trial
Jun 19, 2026 0
Results for "Clonal Hematopoiesis"
20 articles
Regenerative Medicine
NIH Study Tests Bone Marrow Stromal Cells From Multiple Tissues for Bone Regeneration
NIDCR researchers compared stromal cells from bone marrow, skin, spleen, and fat to identify which best regenerates bone and supports blood formation.
Clinical Trial
May 25, 2026 0
Cancer Research
CAR T-Cell Therapy Shows Promise Against Relapsed Blood Cancers in Small Trial
Engineered immune cells target CD19+ cancer cells in patients with treatment-resistant lymphoma and leukemia.
Clinical Trial
Mar 28, 2026 1
Cancer Research
Modified T Cells Show Promise Against Childhood Blood Cancers in NCI Trial
Researchers modified children's own immune cells to fight B-cell leukemia and lymphoma when standard treatments failed.
Clinical Trial
Mar 28, 2026 0
Cancer Research
CAR-T Cell Therapy Shows Promise for Treatment-Resistant Blood Cancers
Small trial tests innovative immune cell therapy for patients with relapsed non-Hodgkin's lymphoma who failed standard treatments.
Clinical Trial
Mar 28, 2026 0
Regenerative Medicine
NIH Study Banks Cord Blood Stem Cells to Unlock Sickle Cell Cures
NHLBI researchers optimize collection and storage of umbilical cord blood from sickle cell-affected and healthy newborns for future stem cell therapies.
Clinical Trial
Jun 17, 2026 0
Cancer Research
CAR-T Cell Therapy Shows Promise Against Treatment-Resistant Multiple Myeloma
Genetically modified immune cells target blood cancer that stopped responding to standard treatments in 28-patient trial.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Engineered Immune Cells Show Promise Against Advanced Cancer in Early Trial
Scientists modified patients' immune cells to better recognize and attack cancer tumors expressing NY-ESO-1 protein.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Turin Study Maps Why Multiple Myeloma Escapes Anti-CD38 Immunotherapy
Italian researchers track genomic and cellular changes in myeloma patients to uncover why anti-CD38 treatments stop working.
Clinical Trial
Jun 16, 2026 0
Cancer Research
Strength Training Fights Inflammaging in Bone Marrow Transplant Survivors
A 10-week supervised strength program targets chronic inflammation and self-efficacy in long-term allogeneic HCT survivors.
Clinical Trial
May 25, 2026 0
Cancer Research
Enhanced CAR-T Cell Therapy Shows Promise Against Treatment-Resistant Blood Cancers
Modified immune cells engineered to overcome cancer's defenses completed safety testing in lymphoma patients.
Clinical Trial
Mar 29, 2026 12
Autoimmune & Arthritis
Placental Stem Cell Secretome Tested as GvHD Treatment in Phase 3 Trial
A completed Phase 3 trial tests placental MSC secretome injections against placebo in 60 GvHD patients at an Iranian hospital.
Clinical Trial
May 12, 2026 0
Cancer Research
Engineered T Cells Show Promise Against Childhood Cancers in Phase I Trial
Modified immune cells targeting GD2 protein demonstrated safety in treating aggressive childhood cancers like neuroblastoma and osteosarcoma.
Clinical Trial
Mar 28, 2026 0
Cancer Research
CD226 Immune Receptor Explored as Predictor of Immunotherapy Response in Advanced Liver Cancer
A French trial investigated whether circulating immune cell profiles, specifically CD226 expression, could predict who responds to Atezolizumab/Bevacizumab in advanced HCC.
Clinical Trial
Jun 9, 2026 0
Cancer Research
Brain Cancer Trial Uses Patient's Own Tumor Cells to Train Immune System
Innovative immunotherapy approach converts patient tumor cells into personalized vaccines to fight aggressive brain cancer.
Clinical Trial
Mar 28, 2026 0
Regenerative Medicine
Blood-Derived Stem Cell Therapy Shows Promise for Critical Limb Ischemia
Autologous stem cell injections tested in patients with severe leg circulation problems who had no surgical options.
Clinical Trial
Mar 29, 2026 1
Cancer Research
Natural Killer Cell Therapy Shows Promise for Advanced Cancer Treatment
Autologous NK cell therapy combined with immunotherapy tested in 27 patients with treatment-resistant cancers.
Clinical Trial
Mar 29, 2026 0
Cancer Research
New Cancer Drug NKTR-255 Shows Promise in Blood Cancer Treatment Trial
Phase 1 trial tests innovative immunotherapy for multiple myeloma and lymphoma patients who didn't respond to standard treatments.
Clinical Trial
Mar 29, 2026 1
Regenerative Medicine
Repeated Stem Cell Injections Show Safety Promise for ALS Patients
A Phase 1/2 trial tests four rounds of intrathecal MSC injections in ALS patients, targeting both safety and disease progression.
Clinical Trial
May 13, 2026 0
Heart Health
REGENXBIO Hunts LDLR Mutations to Build a Gene Therapy Pipeline for Rare Cholesterol Disorder
A completed registry study identified and genotyped HoFH patients with LDLR mutations, laying groundwork for targeted gene therapy.
Clinical Trial
May 28, 2026 0
Page 1 of 2Next